08 apr: Zealand Pharma A/S - optagelse til handel og officiel notering af..
08 apr: Selskabsmeddelelse 5/2019
08-04-2019 08:50:51

GN Store Nord A/S issues options to the executive management and key employees

In accordance with section 3.3.10 of the Nasdaq Copenhagen Rules for Issuers of Shares and with reference to the Remuneration Policy, including General Guidelines for Incentive Pay approved at the annual general meeting on 21 March 2019, the Board of Directors of GN Store Nord A/S (GN) has granted share options to the Executive Management of GN and other carefully selected key employees of the GN Group.

The purpose of the long-term share-based incentive plan is to align the interests of participants to those of GN’s shareholders and thereby support the group’s long-term objective to deliver sustainable value creation for GN’s shareholders.

The grant comprises a total of 784,235 share options in GN of which 581,140 have been issued to employees and 203,095 to the Executive Management.

Main terms and conditions for the share option program

The vesting period for the share options is three years from grant, and vesting is subject to fulfilment of certain performance targets decided by the Board of Directors pertaining to GN’s performance on revenue and earnings growth. These targets reflect GN’s focus on growth relative to peers, which is an essential part of GN’s long-term business strategy.

Performance is measured against a large peer group of listed companies that are similar to GN in terms of size, growth, innovation and are within adjacent industries.

Vesting will take place on a sliding scale depending on the level of GN’s performance compared to the performance of peer group companies; however, a minimum level of performance will have to be achieved for vesting to take place. Likewise, a cap is in place in cases where maximum performance is achieved.

The share options have been granted to the participants free of charge.

Upon vesting, each vested share option may be exercised over a three-year period following publication of GN’s financial reports. Each vested share option entitles the participant to purchase one share in GN at an exercise price of DKK 312.6 per share corresponding to the five-day closing price prior to grant. If vested share options are not exercised within the three-year period, they will lapse without compensation.

The total number of share options which may be exercised under this grant corresponds to 0.5% of GN’s total outstanding shares, however, in case of a maximum performance under the performance targets, the total number of share options, which may be exercised can be up to 100% higher. 

The number of share options granted corresponds to a percentage of the participant’s base salary. The theoretical market value of one share option granted is DKK 68.2 (calculated using the Black Scholes model). The key assumptions for the calculation of the theoretical market value are: share price of 312.6 DKK, exercise price of 312.6 DKK, volatility of 27.4%, average duration of 4.5 years, risk free interest rate of 0% and dividend yield of 0.4%.

In order to avoid excessive payouts in case GN’s share price increases dramatically, the gross return of share value to be received upon exercise of share options under each annual grant will, for the Executive Management, be capped at a maximum of four times the participant’s annual base salary at the time of grant.

GN will cover its obligation to deliver shares upon exercise of vested share options by using treasury shares.

For further information, please see GN’s revised remuneration policy published on our website or contact:

Investors and analysts

Peter Justesen

VP – Investor Relations & Treasury

Tel: +45 45 75 87 16

Or

Rune Sandager

Senior Manager Investor Relations 

Tel: +45 45 75 92 57

Press and the media

Lars Otto Andersen-Lange

Head of Media Relations & Corporate Public Affairs

Tel: +45 45 75 02 55

About GN Group

The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Our ambitious 150-year journey has taken us from telegraph cables to radio waves and intelligent audio engineering. To celebrate our anniversary, we look to our unique competences within medical, professional and consumer audio solutions to help us continue to transform lives through the power of sound. 

GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra and BlueParrott in 100 countries. Founded in 1869, the GN Group employs 6,000 people and is listed on Nasdaq Copenhagen (GN.CO).

Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter.

Attachment

logo.png

Relateret indhold
19 jun - 
Onsdagens aktier: Mærsk sørgede for ny optur
19 jun - 
Aktier/middag: Pandora lyser op i svagt marked
18 jun - 
GN/Commerzbank: Hæver kursmål og gentager "køb"
Relateret debat
25 jun - 
Er der overhovedet noget at hente i denne her aktie, in..
12 jun - 
Den er svær at få styr på undrer mig også mon ikke det ..
12 jun - 
Pludselig stor stigning
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Lars Christensens Verden - Episode 23: Sådan bruger danskerne deres penge

26-06-2019 12:10:56
I denne episode af “Lars Christensens Verden” får du svar på, om der er forskel på kvinders og mænds investeringsadfærd, hvorfor unge mænd bruger så mange penge på gambling, og hvorfor kvinder burde investere mere i aktier.Ugens gæst, privatøkonom og senioranalytiker Louise Aggerstrøm Hansen, Danske Bank, deler sine mange indsigter i de private husholdningers økonomiske adfærd, forbrugsmønstre og ..

Investeringsfirma øger shortpositioner i danske banker

26-06-2019 15:22:53
Investeringsselskabet Merian Global Investors UK har øget sit sats på kursfald i Sydbank og Jyske Bank.Det fremgår af meddelelser fra Finanstilsynet onsdag.Merian Global Investors holder nu 0,60 pct. af aktiekapitalen i Sydbank mod en tidligere shortposition på 0,51 pct. På samme tid har investeringsselskabet øget sin shortposition i Jyske Bank til 0,71 pct. af den samlede aktiekapital fra en posi..

Novo-konkurrent vil have højdosisudgave af Trulicity på markedet

26-06-2019 13:10:48
Det amerikanske medicinalselskab Eli Lilly, der er en af danske Novo Nordisks store konkurrenter, har haft succes i et nyt studie med sin ugentlige GLP-1-analogen Trulicity i højdosisudgaver på 3 og 4,5 milligram.Midlet er i forvejen på markedet i en dosis på 1,5 milligram og konkurrerer med Novo Nordisks midler Victoza og Ozempic.I et studie når højdosisudgaverne af Trulicity til behandling af pa..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Danske Bank-direktør rykker til Nordea
2
Aktier/Saxo Bank: Novo Nordisk har været en af eliteindeksets vindere
3
ABG om Ambu: Topchefs køb af aktier sender et godt signal til markedet
4
Otte topfolk i Amagerbanken skal betale 225 millioner kroner
5
Onsdagens aktier: Ambu glimtede i toppen mens Nilfisk blev straffet

Relaterede aktiekurser

GN Store Nord A/S 306,90 -1,5% Fald i aktiekurs
GN Store Nord Ord Shs 306,90 -1,5% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. juni 2019 08:27:18
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190527.1 - EUROWEB7 - 2019-06-27 08:27:18 - 2019-06-27 08:27:18 - 1 - Website: OKAY